著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Philippe Moreau and Meletios-Athanasios Dimopoulos and Joseph Mikhael and Kwee Yong and Marcelo Capra and Thierry Facon and Roman Hajek and Ivan Špička and Ross Baker and Kihyun Kim and Gracia Martinez and Chang-Ki Min and Ludek Pour and Xavier Leleu and Albert Oriol and Youngil Koh and Kenshi Suzuki and Marie-Laure Risse and Gaelle Asset and Sandrine Macé and Thomas Martin and Ivan Spicka and Kim Kihyun and Min Chang-Ki and Koh Youngil and Tom Martin and Hang Quach and Andrew Lim and Helen Crowther and Hanlon Sia and Cyrille Hulin and Mohamad Mohty and Gabor Mikala and Zsolt Nagy and Marta Reinoso Segura and Laura Rosinol and Munci Yagci and Mehmet Turgut and Mamta Garg and Gurdeep Parmar and Brad Augustson and Nelson Castro and Edvan Crusoe and Tomas Pika and Sosana Delimpasi and Kenichi Ishizawa and Anup George and Tatiana Konstantinova and Javier De La Rubia and Kim Sung-Hyun and Angelo Maiolino and Anthony Reiman and Richard LeBlanc and Shigeki Ito and Junji Tanaka and Alexander Luchinin and Irina Kryuchkova and Joaquin Martinez and Jesse Shustik and Lionel Karlin and Anargyros Symeonidis and Miklos Egyed and Mario Petrini and Michele Cavo and Michihiro Uchiyama and Hilary Blacklock and Mutlu Arat and James Griffin and Hannah Hunter and Tonda Buck and Achilles Anagnostopoulos and Konstantinos Konstantopoulos and Tamas Masszi and Sara Bringhen and Barbara Gamberi and Yawara Kawano and Kim Jin Seok and Hakan Ozdogu and Fahir Ozkalemkas,"Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial",The Lancet,0140-6736,Elsevier BV,2021-06,397,10292,2361-2371,https://cir.nii.ac.jp/crid/1360017287056705536,https://doi.org/10.1016/s0140-6736(21)00592-4